9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer

Benzer Materyaller

• Clinically relevant GSK-3β inhibitor 9-ING-41 is active as a single agent and in combination with other antitumor therapies in human renal cancer
  Yazar:: Anraku, Tsutomu, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment
  Yazar:: Kuroki, Hiroo, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents
  Yazar:: Karmali, Reem, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• ATPS-91 GSK-3 INHIBITOR 9-ING-41 ENHANCES GENOTOXIC THERAPY OF GBM LEADING TO CURE FROM INTRACRANIAL BRAIN TUMOR
  Yazar:: Ugolkov, Andrey, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models()()
  Yazar:: Ugolkov, Andrey, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)